0001209191-23-036145.txt : 20230612
0001209191-23-036145.hdr.sgml : 20230612
20230612090230
ACCESSION NUMBER: 0001209191-23-036145
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230608
FILED AS OF DATE: 20230612
DATE AS OF CHANGE: 20230612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PRYGOCKI MARK A SR
CENTRAL INDEX KEY: 0001257544
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38529
FILM NUMBER: 231007211
MAIL ADDRESS:
STREET 1: C/O MEDICS
STREET 2: 8125 N. HAYDEN RD
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85258
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verrica Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001660334
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463137900
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 NORTH HIGH STREET
STREET 2: SUITE 200
CITY: WEST CHESTER
STATE: PA
ZIP: 19380
BUSINESS PHONE: 484-453-3300
MAIL ADDRESS:
STREET 1: 10 NORTH HIGH STREET
STREET 2: SUITE 200
CITY: WEST CHESTER
STATE: PA
ZIP: 19380
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-08
0
0001660334
Verrica Pharmaceuticals Inc.
VRCA
0001257544
PRYGOCKI MARK A SR
C/O VERRICA PHARMACEUTICALS INC.
44 WEST GAY STREET, SUITE 400
WEST CHESTER
PA
19380
1
0
0
0
0
Stock Option (right to buy)
5.70
2023-06-08
4
A
0
10384
0.00
A
2033-06-07
Common Stock
10384
10384
D
The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 8, 2023 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date.
/s/ Mark Ballantyne, Attorney-in-Fact
2023-06-12